| Title: | Deep learning methods may not outperform other machine learning methods on analyzing genomic studies |
| Journal: | Frontiers in Genetics |
| Published: | 23 Sep 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36212148/ |
| DOI: | https://doi.org/10.3389/fgene.2022.992070 |
| URL: | https://www.frontiersin.org/articles/10.3389/fgene.2022.992070/pdf |
| Citations: | 6 (6 in last 2 years) as of 8 Aug 2024 |
Publication 8146
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Deep Learning (DL) has been broadly applied to solve big data problems in biomedical fields, which is most successful in image processing. Recently, many DL methods have been applied to analyze genomic studies. However, genomic data usually has too small a sample size to fit a complex network. They do not have common structural patterns like images to utilize pre-trained networks or take advantage of convolution layers. The concern of overusing DL methods motivates us to evaluate DL methods' performance versus popular non-deep Machine Learning (ML) methods for analyzing genomic data with a wide range of sample sizes. In this paper, we conduct a benchmark study using the UK Biobank data and its many random subsets with different sample sizes. The original UK Biobank data has about 500k participants. Each patient has comprehensive patient characteristics, disease histories, and genomic information, i.e., the genotypes of millions of Single-Nucleotide Polymorphism (SNPs). We are interested in predicting the risk of three lung diseases: asthma, COPD, and lung cancer. There are 205,238 participants have recorded disease outcomes for these three diseases. Five prediction models are investigated in this benchmark study, including three non-deep machine learning methods (Elastic Net, XGBoost, and SVM) and two deep learning methods (DNN and LSTM). Besides the most popular performance metrics, such as the F1-score, we promote the hit curve, a visual tool to describe the performance of predicting rare events. We discovered that DL methods frequently fail to outperform non-deep ML in analyzing genomic data, even in large datasets with over 200k samples. The experiment results suggest not overusing DL methods in genomic studies, even with biobank-level sample sizes. The performance differences between DL and non-deep ML decrease as the sample size of data increases. This suggests when the sample size of data is significant, further increasing sample sizes leads to more performance gain in DL methods. Hence, DL methods could be better if we analyze genomic data bigger than this study.7 Authors
- Yao Dong
- Shaoze Zhou
- Li Xing
- Yumeng Chen
- Ziyu Ren
- Yongfeng Dong
- Xuekui Zhang
Enabling scientific discoveries that improve human health